# US 2011/0301153 A1 · Methods of treating cancer

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2011/0301153 A1
- Document ID: US20110301153A1
- Status: Published application
- Kind: A1
- Application number: 13/129,679
- Filed: 2009-11-16
- Published: 2011-12-08
- Earliest claimed: 2008-11-17
- Assignees: The Trustees of the University of Pennsylvania
- Inventors: Craig B. Thompson; David R. Wise
- Web page: https://patentgrep.com/patent/US20110301153A1

## CPC

- A61K 31/00: Medicinal preparations containing organic active ingredients
- A61P 35/00: Antineoplastic agents
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The invention concerns methods of treating cancer comprising contacting said tumors with a chemical inhibitor of glutaminolysis. These inhibitors include amino-oxyacetate, phenylbutyrate, phenylacetate, and 3,7-bis(dimethylamino)-phenazathionium chloride (methylene blue).

## Claims

### Claim 1

A method of treating cancer comprising contacting said tumors with a chemical inhibitor of glutaminolysis.

### Claim 2 (depends on 1)

The method of claim 1, wherein said chemical inhibitor of glutaminolysis comprises one or more of amino-oxyacetate, phenylbutyrate, phenylacetate, and 3,7-bis(dimethylamino)-phenazathionium chloride (methylene blue).

### Claim 3 (depends on 1)

The method of claim 1, wherein said cancer is cancer of the lung, breast, colon, or prostate.

### Claim 4 (depends on 1)

The method of claim 1, wherein the cancer is lymphoma, bronchoalvedar cell lung carcinoma, or carcinold tumor.

### Claim 5

A method of treating a Myc-induced tumor comprising contacting said tumors with a chemical inhibitor of glutaminolysis.

### Claim 6 (depends on 5)

The method of claim 5, wherein said chemical inhibitor of glutaminolysis comprises one or more of amino-oxyacetate, phenylbutyrate, phenylacetate, and 3,7-bis(dimethylamino)-phenazathionium chloride (methylene blue).

### Claim 7 (depends on 5)

The method of claim 5, wherein said tumor is associated with cancer of the lung, breast, colon, or prostate.

### Claim 8 (depends on 5)

The method of claim 5, wherein the tumor is related to lymphoma, bronchoalvedar cell lung carcinoma, or carcinold tumor.

### Claim 9

A method of inhibiting glutaminolysis in a Myc expressing cell comprising contacting said cell with one or more of amino-oxyacetate, phenylbutyrate, phenylacetate, and 3,7-bis(dimethylamino)-phenazathionium chloride (methylene blue).

### Claim 10

A method of preventing cancer comprising contacting Myc expressing cells with one or more of amino-oxyacetate, phenylbutyrate, phenylacetate, and 3,7-bis(dimethylamino)-phenazathionium chloride (methylene blue).
